More News! 30 Nov 2022
FDA grants Sensorion Orphan Drug Designation for hearing loss drug
…half of 2023. Sensorion’s OTOF-GT dual vector AAV gene therapy development program aims to restore hearing in people living with otoferlin deficiency. Patients with mutations in OTOF suffer from severe…